Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
Wenjia Chen, Mohsen Sadatsafavi, Trung N. Tran, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 1491-1510
Open Access | Times Cited: 14

Showing 14 citing articles:

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
David J. Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 1, pp. 2301521-2301521
Open Access | Times Cited: 19
Non-T2 asthma
Emily K. Duffus, Fernando Holguin, Deepa Rastogi
Current Opinion in Pulmonary Medicine (2025)
Closed Access | Times Cited: 1
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Wenjia Chen, Trung N. Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2732-2747
Open Access | Times Cited: 18
Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study
Trung N. Tran, Stephanie Chen, Benjamin Emmanuel, et al.
Pragmatic and Observational Research (2025) Vol. Volume 16, pp. 51-66
Open Access
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
Wenjia Chen, Helen K. Reddel, J Mark FitzGerald, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Severe asthma care trajectories: the French RAMSES cohort
Jeanne‐Marie Perotin, Lisa Gauquelin, N. Just, et al.
ERJ Open Research (2024) Vol. 10, Iss. 2, pp. 00837-2023
Open Access | Times Cited: 4
Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR
So‐Young Park, Sun-Kyung Lee, Woo‐Jung Song, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 3, pp. 253-253
Open Access | Times Cited: 4
Clinical and allergological characteristics of patients with severe bronchial asthma in the regional registry and phenotyping principles for the targeted therapy choice
В. В. Наумова, Е. К. Beltyukov, О. П. Ковтун, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 9, pp. 47-61
Open Access | Times Cited: 3
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, et al.
Pragmatic and Observational Research (2024) Vol. Volume 15, pp. 45-51
Open Access | Times Cited: 2
Big Data Research on Severe Asthma
Sang Hyuk Kim, Youlim Kim
Tuberculosis & respiratory diseases (2024) Vol. 87, Iss. 3, pp. 213-220
Open Access | Times Cited: 2
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry
Tham Le, David Price, Clement Erhard, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1055-1069
Open Access | Times Cited: 2
Targeted therapy for severe bronchial asthma: Phenotyping of patients and algorithm for selecting a genetically engineered biological drug
В. В. Наумова, К. А. Зыков, Rudolf Valenta, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 20, pp. 82-91
Open Access
Addressing therapeutic inertia for asthma biologics: Lessons from the KOFU study
Tsutomu Tamada, Hisatoshi Sugiura
Respiratory Investigation (2023) Vol. 61, Iss. 6, pp. 815-823
Open Access
Biologic treatment eligibility and characteristics of Romanian patients with severe asthma: Real-world data from the RECOGNISE study
Dragos Nicolosu, Dragos Gabriel Ungureanu, Violeta Perlea, et al.
Pneumologia (2023) Vol. 72, Iss. 1, pp. 105-118
Open Access
Page 1

Scroll to top